Who Owns VRCA?

Verrica Pharmaceuticals Inc. — Institutional Ownership & 13F Holdings

$6.56

-0.27 (-3.88%)

Market Cap

$53.9M

Shares Outstanding

10,651,796

Institutional Holders

75

Total Inst. Value

$13.8M

% of Float Held

QoQ Holder Change

+20

Institutional data as of Q1 2025

New Positions

13

Closed Positions

16

Increased

29

Decreased

11

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Caligan Partners LP$4.0M8,992,954
2ARMISTICE CAPITAL, LLC$3.8M8,567,400
3BOOTHBAY FUND MANAGEMENT, LLC$1.2M2,807,346
4VANGUARD GROUP INC$1.0M2,361,321
5NORTHWESTERN MUTUAL WEALTH MANAGEMENT CONew$779K1,761
6BlackRock, Inc.$543K1,227,554
7GEODE CAPITAL MANAGEMENT, LLC$449K1,018,486
8UBS Group AG$349K790,163
9STATE STREET CORP$250K567,048
10NORTHERN TRUST CORP$192K434,748

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold VRCA?

As of Q1 2025, 75 institutional investors report holding VRCA (Verrica Pharmaceuticals Inc.) in their 13F filings.

Which hedge fund owns the most VRCA?

The largest institutional holder of VRCA is Caligan Partners LP with $4.0M in shares.

Are institutions buying or selling VRCA?

This quarter, 13 institutions opened new positions in VRCA and 16 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.